How Dr. Dave Rabin’s pursuit of safety, empathy, and evidence is reshaping the way psychiatry understands recovery.
This week’s trip: Phase 3 momentum, one-dose depression signals, ancient mystery science, and relationship research as policy inches forward behind public behavior.
A joy-first mushroom retreat in Jamaica that treats laughter and play like real medicine, not a bonus.
This week’s trip: a national microdosing surge, new research signals, and policy pressure rising as public behavior moves faster than the system.
Ask.Psychedelics.com — Honest answers. Real sources. One search.
Inside the “everything and nothing” state: what 5-MeO-DMT does to experience, and what Imperial College London is finding in the brain.
Turkey tail, cordyceps, and the power of compliance rules.
A wild mushroom triggers “fairytale human” visions. It contains zero psilocybin.
A veteran-led nonprofit proves its psychedelic healing model works. The VA says it doesn’t even meet “threshold requirements.”
This week’s trip: new LSD data conflicts across trials, microdosing takes a complicated turn, and anecdotal reports keep the debate alive.
This week’s trip: ibogaine policy takes center stage, veterans drive the movement for change, and psilocybin meets the science of longevity.
This week’s trip: the world unites for healing, Hollywood resurrects the government's use of LSD and mind control, and scientists keep finding proof that consciousness is anything but ordinary.
